Skip to main content
BRTX logo
BRTX
(NASDAQ)
BioRestorative Therapies, Inc.
$0.23-- (--)
Loading... - Market loading

BioRestorative Therapies (BRTX) Stock Price & Financial Analysis

BioRestorative Therapies Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.22 - $0.24
52-Week High$1.89
52-Week Low$0.16
Open$0.23
Volume160.31K
Average Volume (3M)351.60K
Market Cap4.00M
Shares Outstanding17.73M
Price to Sales (P/S)10.11
Price to Book (P/B)0.02
EV/EBITDA-0.04
Revenue (TTM)357.87K
Net Income (TTM)-11.06M
Free Cash Flow (TTM)-11.90M
EPS (TTM)$-0.99
Profit Margin-3089.55%
Operating Margin-3979.41%
Return on Equity (ROE)-6.31%
Debt to Equity0.00
50-Day MA$0.34
200-Day MA$0.64
52-Week Change-85.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BioRestorative Therapies

What is the current stock price for BRTX?

As of the latest trading session, BRTX stock trades at $0.23. The 52-week range is $0.16–$1.89, with a day range of $0.22–$0.23.

What is the P/E ratio for BRTX?

The P/E ratio (Price-to-Earnings) for BRTX is shown in the Key Statistics section. This valuation metric helps compare BioRestorative Therapies, Inc. to industry peers.

Does BRTX pay dividends?

BioRestorative Therapies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BRTX?

Analyst ratings and recommendations for BRTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BRTX?

BioRestorative Therapies's market capitalization is $4.0M, classifying it as a micro-cap company. BioRestorative Therapies operates in the Healthcare sector within the Biotechnology industry.